• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IN2BONES SAS QUANTUM®; QUANTUM® TOTAL ANKLE PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IN2BONES SAS QUANTUM®; QUANTUM® TOTAL ANKLE PROSTHESIS Back to Search Results
Catalog Number M50 ST231
Device Problems Failure to Osseointegrate (1863); Loss of Osseointegration (2408)
Patient Problems Pain (1994); Implant Pain (4561)
Event Date 05/10/2023
Event Type  malfunction  
Manufacturer Narrative
Investigations are in-progress.A complete and final mdr-report will be submitted when all investigations are performed.
 
Event Description
The quantum® total ankle prosthesis is indicated as a total ankle replacement in primary or revision surgery for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis.The quantum® total ankle prosthesis is a fixed-bearing, semi-constraint ankle prothesis with 2 components and composed of: a tibial component composed of a metallic (ta6v) tibial tray implant fixed to a polymer (uhwmpe) insert, a metallic (cocr) talar implant reproducing the talus dome anatomy.When all components are implanted, with the insert rigidly locked to the tibial tray, the polyethylene insert acts as a single bearing along the talar dome, enabling flexion/extension and rotation movement at the replaced ankle joint.Each component of the quantum® total ankle prosthesis exists in different sizes and models.Event description : a revision surgery to replace a quantum tibial implant is being planned by a french surgeon.This revision surgery is due to the detection of lucencies around the tibial implant and the presence of cysts around the tibial implant cross; associated to pain for the patient.Additional information are to be collected and investigations are in progress.
 
Event Description
The quantum® total ankle prosthesis is indicated as a total ankle replacement in primary or revision surgery for patients with ankle joints damaged by severe rheumatoid, post-traumatic, or degenerative arthritis.The quantum® total ankle prosthesis is a fixed-bearing, semi-constraint ankle prothesis with 2 components and composed of: - a tibial component composed of a metallic (ta6v) tibial tray implant fixed to a polymer (uhwmpe) insert, - a metallic (cocr) talar implant reproducing the talus dome anatomy.When all components are implanted, with the insert rigidly locked to the tibial tray, the polyethylene insert acts as a single bearing along the talar dome, enabling flexion/extension and rotation movement at the replaced ankle joint.Each component of the quantum® total ankle prosthesis exists in different sizes and models.Event description : a revision surgery to replace a quantum tibial implant is being planned by a french surgeon.This revision surgery is due to the detection of lucencies around the tibial implant and the presence of cysts around the tibial implant cross; associated to pain for the patient.Note the initial revision surgery planned on (b)(6) 2023 has been postponed due to the patient comorbidities (diabetes).The revision has not been performed to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUANTUM®
Type of Device
QUANTUM® TOTAL ANKLE PROSTHESIS
Manufacturer (Section D)
IN2BONES SAS
28 chemin du petit bois
bâtiment 2
ecully, 69130
FR  69130
Manufacturer (Section G)
IN2BONES SAS
28 chemin du petit bois
bâiment 2
ecully, 69130
FR   69130
Manufacturer Contact
sabina ahaddad
28 chemin du petit bois
bâtiment 2
ecully, 69130
FR   69130
MDR Report Key17097128
MDR Text Key316883442
Report Number3010470577-2023-05071
Device Sequence Number1
Product Code HSN
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K191380
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberM50 ST231
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age58 YR
Patient SexFemale
-
-